Japanese encephalitis vaccine, inactivated (Valneva Austria GmbH)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameJapanese encephalitis vaccine, inactivated (Valneva Austria GmbH)
Drug Alias NameIC-51IxiaroIC-51
ClassificationVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEncephalitis, JapaneseEncephalitis, Viral
Global Approved IndicationsEncephalitis, JapaneseEncephalitis, Viral
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2009/03/30
Country/TerritoryUnited StatesPhilippinesUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesValneva
China Registration ClassN/A

Develop Information

Active CompaniesValneva Austria Gmbh
Inactive CompaniesN/A
Active IndicationsEncephalitis, JapaneseEncephalitis, Viral
Inactive IndicationsN/A

Other Information

ATC CodeJ07BA02
Related LinksN/A